The House easily passed the bipartisan “21st Century Cures Act” yesterday. Among its numerous provisions, the bill allocates $4.8 billion over 10 years to the National Institutes of Health in support of the Obama administration’s Cancer Moonshot, BRAIN, and Precision Medicine Initiatives, and creates a Research Policy Board tasked with identifying means of reducing administrative burdens.
At a Senate hearing, appropriations subcommittee leaders disagreed on the advisability of the federal government embarking on an effort to spur the development and deployment of new types of nuclear reactors.
The National Nanotechnology Initiative has released the triennial update of its strategic plan. Among its new features, the plan now stresses the need to further develop the nanotechnology community’s collaboration “ecosystem” and to promote the development and sharing of data, computer models, and simulations.
In a letter to President-elect Donald Trump, the CEOs of 29 national scientific societies are calling on Trump to quickly appoint a science advisor and draw on S&T expertise to address national challenges.
In a June 2016 white paper, James Carafano, a Heritage Foundation analyst who is now a member of Trump’s transition team, made a series of science policy recommendations for the next U.S. president, including eliminating the White House Office of Science and Technology Policy.